NewHold Investment Corp III NWCL

Rütschi, a newcleo Group pump designer and manufacturer, celebrates its 80th anniversary in Illzach, Alsace. Founded in Switzerland in 1946 and active in Alsace since 1970, the unit has delivered over 5,200 pumps to more than 110 nuclear plants worldwide, including all French reactors, with duties in cooling, safety, and effluent management. The milestone underlines its role in supporting existing fleets and preparing for future reactors across France and internationally. A 12-year EDF framework signed in 2025 covers pumps for future projects, including EPR2. A €3 million modernization in Illzach will upgrade test benches and add assembly lines for EPR2 and newcleo’s advanced reactors, employing about 60 staff. Rütschi’s integration with newcleo, SRS, and Fucina Italia aims to strengthen industrialisation and supply of critical components. Initial pump prototype for liquid lead testing will be delivered to ENEA Brasimone. Demonstrates expanded nuclear supply capabilities and long-term EDF contracts within the group, modestly benefiting NWCL's prospects.

Newcleo (NWCL) was added to the Nasdaq Composite after closing a US$216 million private placement tied to its Nasdaq Global Select Market listing. Despite the high-profile move, the stock has weakened: down 16.7% over the past week, 26.3% over the past month, and 23.1% in the last year, trading around $7.83. Valuation remains murky with no earnings history, no analyst targets, and insufficient data for price-to-book or discounted cash flow calculations, leaving prices driven by story and balance-sheet expectations rather than traditional metrics. The article notes a neutral P/B signal ('about right') but warns sector sentiment toward nuclear and future funding terms could quickly erode upside. In short, index inclusion and new capital boost visibility, but momentum and funding risk cap potential gains. Index inclusion and fresh funding improve visibility and liquidity, but absence of earnings data and P/B clarity keeps valuation uncertain and dampens near-term upside.

newcleo SA announced its ordinary shares and warrants will begin trading on Nasdaq Global Select Market today, Sept. 22, 2026, under tickers NWCL and NWCLW. CEO Stefano Buono called the listing a pivotal milestone to accelerate deployment of its advanced modular reactor technology and nuclear fuel manufacturing across Europe and the United States, with the aim of closing the nuclear fuel cycle. The listing is expected to support global growth as newcleo completes its 10 MWth non-nuclear demonstrator in Italy, advances regulatory interactions with U.S. and French nuclear safety authorities, and pursues commercial opportunities to deploy reactors and fuel facilities in the U.S. and Europe. newcleo employs more than 900 people across Europe and the U.S. and develops lead-cooled fast reactors with recycled-material fuel through a vertically integrated supply chain and partnerships. Nasdaq listing enhances liquidity, access to capital, and credibility, potentially accelerating growth and deployment while regulatory milestones and execution risk remain key.

Newcleo has completed its business combination with NewHold Investment Corp III, raising approximately $247 million gross to fuel U.S. and European growth and advance its lead-cooled fast reactor and MOX fuel production to commercialization. The deal values Newcleo at about $2.4 billion pre-money, comprising a $216 million oversubscribed PIPE and $31 million from NewHold’s trust, with up to $75 million more available under a forward purchase agreement. Newcleo’s ordinary shares and warrants will begin trading on Nasdaq under the symbols NWCL and NWCLW on September 22, 2026. The public-company board is led by Jeffrey Lyash, and Newcleo’s existing management will continue to lead the combined business. Proceeds will support the 10MWth Italy demonstrator, regulatory licensing discussions in the U.S. and France, and global deployment of reactors and fuel facilities. Total funds raised to date exceed $1 billion. Forward-looking statements accompany the release. Closing creates a significant capital event and Nasdaq-ready platform for the combined company, likely altering NHIC's valuation and investor perception.

NewHold Investment Corp. III shareholders approved the business combination with newcleo plc. Shareholder approval completes the merger and converts NHIC into the public vehicle for newcleo.

newcleo appoints nuclear industry veteran Jeffrey Lyash as Chairman of the Board. Board appointment at newcleo adds experienced leadership that may moderately support NHIC's positioning in nuclear sector.

Newcleo-led consortium awarded funding to develop floating nuclear reactors for decarbonisation of French maritime sector. Funding award advances newcleo's core nuclear project with direct positive implications for NHIC trajectory.

NewHold Investment Corp. III and newcleo Ltd. announced SEC effectiveness of Form F-4 registration statement for proposed business combination and Nasdaq listing. Business combination with newcleo and Nasdaq listing will fundamentally transform NHIC's operations and market position.

newcleo advances MOX fuel licensing in France and enters new collaboration phase with French authorities. MOX fuel licensing progress and French authority collaboration significantly enhance newcleo's position affecting NHIC performance.

Newcleo plans Nasdaq listing through merger with NewHold Investment Corp III, boosting interest in advanced nuclear technologies. Merger with newcleo positions NHIC for major growth in advanced nuclear sector.

NewHold Investment Corp. III and newcleo Ltd. filed a registration statement on Form F-4 with the SEC for their proposed business combination. SEC filing advances merger with newcleo Ltd. and marks major step toward NHIC becoming an operating entity.

newcleo acquires nuclear scales manufacturer Bonifait Pesage to strengthen vertical integration. Acquisition represents major strategic move strengthening newcleo's nuclear operations and directly lifting NHIC trajectory.

Newcleo merges with NewHold Investment Corp III (NHIC) to list publicly in the US via SPAC. SPAC merger directly executes NHIC's core mandate and triggers major valuation and trading changes.

Newcleo plans to go public in the US by merging with NewHold Investment III. Merger enables NHIC to facilitate Newcleo's US listing and triggers major valuation and market shifts.

newcleo to become public company via business combination with NewHold Investment Corp III. Merger delivers nuclear reactor business to NHIC and redefines its market position.